Evidence map›Paper›PMID 39062701›Full record

ArticleGenes2024

Exploring Microorganisms Associated to Acute Febrile Illness and Severe Neurological Disorders of Unknown Origin: A Nanopore Metagenomics Approach.

Keldenn Melo Farias Moreno, Virgínia Antunes de Andrade, Felipe Campos de Melo Iani, Vagner Fonseca, Maurício Teixeira Lima, Emerson de Castro Barbosa, Luiz Marcelo Ribeiro Tomé, Natália Rocha Guimarães, Hegger Machado Fritsch, Talita Adelino and 5 more

Abstract read
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Keldenn Melo Farias MorenoInstitute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Virgínia Antunes de AndradeEduardo de Menezes Hospital, Belo Horizonte 30622-020, Brazil.
Felipe Campos de Melo IaniCentral Public Health Laboratory of the State of Minas Gerais, Ezequiel Dias Foundation, Belo Horizonte 30510-010, Brazil.ORCID 0000-0002-3629-8529
Vagner FonsecaDepartment of Exact and Earth Sciences, University of the State of Bahia, Salvador 41150-000, Brazil.ORCID 0000-0001-5521-6448
Maurício Teixeira LimaInstitute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0002-0830-3909
Emerson de Castro BarbosaRené Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, Brazil.ORCID 0000-0002-3210-7342
Luiz Marcelo Ribeiro ToméRené Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, Brazil.
Natália Rocha GuimarãesRené Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, Brazil.
Hegger Machado FritschInstitute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0002-1997-5786
Talita AdelinoCentral Public Health Laboratory of the State of Minas Gerais, Ezequiel Dias Foundation, Belo Horizonte 30510-010, Brazil.ORCID 0000-0002-1471-0084
Tatiana Oliveira FereguettiEduardo de Menezes Hospital, Belo Horizonte 30622-020, Brazil.
Maíra Cardoso AspahanEduardo de Menezes Hospital, Belo Horizonte 30622-020, Brazil.
Tereza Gamarano BarrosEduardo de Menezes Hospital, Belo Horizonte 30622-020, Brazil.
Luiz Carlos Junior AlcantaraRené Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, Brazil.
Marta GiovanettiDepartment of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-5849-7326

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
ICGEB CRP/BRA20-03NIAID NIH HHS U01 AI151698NIH HHS U01 AI151698
6 · The paper itself

Abstract

Acute febrile illness (AFI) and severe neurological disorders (SNDs) often present diagnostic challenges due to their potential origins from a wide range of infectious agents. Nanopore metagenomics is emerging as a powerful tool for identifying the microorganisms potentially responsible for these undiagnosed clinical cases. In this study, we aim to shed light on the etiological agents underlying AFI and SND cases that conventional diagnostic methods have not been able to fully elucidate. Our approach involved analyzing samples from fourteen hospitalized patients using a comprehensive nanopore metagenomic approach. This process included RNA extraction and enrichment using the SMART-9N protocol, followed by nanopore sequencing. Subsequent steps involved quality control, host DNA/cDNA removal, de novo genome assembly, and taxonomic classification. Our findings in AFI cases revealed a spectrum of disease-associated microbes, including

Indexed as

MetagenomicsNanopore SequencingAdultAgedEscherichia coliFemaleFeverHumansMaleMetagenomeMiddle AgedNanoporesNervous System Diseasesacute febrile illnessmetagenomicsnanopore sequencingsevere neurological disorders

Identifiers

PMID39062701
PMCPMC11276239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.